RPID
Rapid Micro Biosystems, Inc.NASDAQHealthcare$2.27+5.09%ClosedMarket Cap: $103.2M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
3.05
P/S
3.07
EV/EBITDA
-2.43
DCF Value
$-17.96
FCF Yield
-30.1%
Div Yield
0.0%
Margins & Returns
Gross Margin
17.4%
Operating Margin
-141.1%
Net Margin
-140.3%
ROE
-95.4%
ROA
-63.0%
ROIC
-82.2%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $11.3M | 10.7% | $-12.2M | $-12.5M | $-0.28 | — |
| FY 2025 | $33.6M | 22.7% | $-47.4M | $-47.1M | $-1.05 | — |
| Q3 2025 | $7.8M | 29.0% | $-11.4M | $-11.5M | $-0.25 | — |
| Q2 2025 | $7.3M | 26.8% | $-12.1M | $-11.9M | $-0.27 | — |
| Q1 2025 | $7.2M | 5.6% | $-11.7M | $-11.3M | $-0.26 | — |
| Q4 2024 | $8.2M | 11.9% | $-10.2M | $-9.7M | $-0.22 | — |
| FY 2024 | $28.1M | -0.4% | $-49.9M | $-46.9M | $-1.08 | — |
| Q3 2024 | $7.6M | 8.2% | $-12.0M | $-11.3M | $-0.26 | — |
| Q2 2024 | $6.6M | -2.9% | $-13.4M | $-12.6M | $-0.29 | — |
| Q1 2024 | $5.6M | -27.1% | $-14.3M | $-13.3M | $-0.31 | — |
| Q4 2023 | $6.3M | -2.7% | $-12.2M | $-11.2M | $-0.26 | — |
| FY 2023 | $22.5M | -24.4% | $-56.6M | $-52.5M | $-1.22 | — |